Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis

INTRODUCTION: Long-term treatment of pulmonary sarcoidosis with glucocorticoids has been associated with toxicity and other adverse events, highlighting the need for alternative therapies. The goal of this study was to evaluate the efficacy and safety of repository corticotropin injection (RCI, Acth...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirsaeidi, Mehdi, Baughman, Robert P., Sahoo, Debasis, Tarau, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113127/
https://www.ncbi.nlm.nih.gov/pubmed/37072607
http://dx.doi.org/10.1007/s41030-023-00222-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113127/
https://www.ncbi.nlm.nih.gov/pubmed/37072607
http://dx.doi.org/10.1007/s41030-023-00222-2

Ejemplares similares